Immumohistochemical identification method of tumour cells in the S phase of mitotic cycle and its usefulness in diagnostics of mammary gland adenocarcinomas in bitches

Polish Journal of Veterinary Sciences

Volumn 9, Issue 1, 2006, Pages 57-62

  Nowak, M ^a   Madej, J A ^a   Dziegiel P ^b   Kanzawa, H ^c  

^a WROCLAW UNIVERSITY OF ENVIRONMENTAL AND LIFE SCIENCES   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c Specialistic Hospital for Animals Kanzawa   (Poland)

Author keywords

Bitches; BrdU; Mammary gland carcinoma; Monoclonal antibody to BrdU

Indexed keywords

CANIDAE;

BROXURIDINE; CYCLINE; KI 67 ANTIGEN;

ADENOCARCINOMA; ANIMAL; ANIMAL DISEASE; ARTICLE; BIOSYNTHESIS; CELL CYCLE S PHASE; CELL DIVISION; DOG; DOG DISEASE; EXPERIMENTAL NEOPLASM; FEMALE; IMMUNOHISTOCHEMISTRY; METABOLISM; MITOSIS; PATHOLOGY; PHYSIOLOGY;

ADENOCARCINOMA; ANIMALS; BROMODEOXYURIDINE; CELL DIVISION; DOG DISEASES; DOGS; FEMALE; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MAMMARY NEOPLASMS, ANIMAL; MITOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; S PHASE;

EID: 33645101029     PISSN: 15051773     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Barnard NJ, Hall PA, Lemoine NR, Kadarr N (1987) Proliferative index in breast carcinoma determined in situ by Ki-67 immunostaining and its relationship to clinical and pathological variables. J Pathol 152: 287-295.
2. Bianco P, Robey P (2001) Stem cells in tissue engineering. Nature 414: 118-121.
3. Brown DC, Gatter KC (1990) Monoclonal antibody Ki-67: its use in histopathology. Histopathology 17: 489-503.
4. Dietrich DR (1993) Toxicological and pathological applications of proliferating cell nuclear antigen (PCNA), a novel endogenous marker for cell proliferation. Crit Rev Toxicol 23: 77-109.
5. Dionigi P, Ferrari A, Jemos V, Luinetti O, Vai L, Guizzetti M, Ferrari C, Jemos K, Spada M, Mazzini G (2004) Tumor cell proliferation in early gastric cancer: biological and clinical behavior. Hepatogastroenterology 51: 264-268.
6. Fujimaki T, Matsutani M, Nakamura O, Asai A, Funada N, Koike M, Segawa H, Aritake K, Fukushima T, Houjo S (1991) Correlation between bromodeoxyuridine- labeling indices and patient prognosis in cerebral astrocytic tumors of adults. Cancer 67: 1629-1634.
7. Gerdes J, Shwab U, Lemke H, Baisch H, Wacker HH (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated witch cell proliferation. Int J Canc 31: 13-20.
8. Giziński S, Boryczko Z, Katkiewicz M, Bostedt H (2003) Ki-67 protein as a prognostic factor in mammary gland tumors in female dogs. Med Weter 59: 888-891.
9. Liu Y, Rao MS (2003) Transdifferentiation - fact or artifact? Cloning Stem Cells 1: 29-40.
10. Meyer JS, Koehm SL, Hughes JM, Higa E, Wittliff JL, Lagos JA, Manes JL (1993) Bromodeoxyuridine labeling for S-phase measurement in breast carcinoma. Cancer 71: 3531-3540.
11. Miller MA, Mazewski CM, Yousuf N, Sheikh Y, White LM, Yanik GA, Hyams DM, Lampkin BC, Raza A (1991) Simultaneous immunohistochemical detection of IUdR and BrdU infused intravenously to cancer patients. J Histochem Cytochem 39: 407-412.
12. Morrison SJ, Shah NM, Anderson DJ (1997) Regulatory mechanisms in stem cell biology. Cell 88: 287-298.
13. Nagashima T, DeArmond SJ, Murovic J, Hoshino T (1985) Immunocytochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumor tissues. Acta Neuropathol (Berl) 67: 155-159.
14. Nemoto R, Hattori K, Uchida K, Shimazui T, Nishijima Y, Koiso K, Harada M (1990) S-phase fraction of human prostate adenocarcinoma studied with in vivo bromodeoxyuridine labeling. Cancer 66: 509-514.
15. Ota T, Akaza H, Hattori K, Uchida K (1997) The relationship between the estimated tumor growth speed and indices of bromodeoxyuridine (BrdU) incorporation and the proliferating cell nuclear antigen (PCNA) expression in superficial bladder cancer. Nippon Hinyokika Gakkai Zasshi 88: 868-873.
16. Podbielski M (1997) Proliferative activity of tumour cells in animals with particular attention payed to the role of Ki-67 and PCNA. From the First Scientific Conference on Veterinarian Oncology: progress in diagnosis and in therapy. Olsztyn 4-5.09.1997: 85-93.
17. Quinn CM, Wright NA (1990) The clinical assessment of proliferation and growth in human tumors: evaluation of methods and applications as prognostic variables. J Pathol 121: 13-24.
18. Solter D, Gearhart J (1999) Enhaced: putting stem cells to work. Science 283: 1468-1470.
19. Tonemura Y, Kamata T, Ooyama S, Sugiyama K, Kimura H, Kosaka T, Yamaguchi A, Miyazaki I (1990) Relation of proliferative activity to survival in patients with gastric carcinoma. J Surg Oncol 43: 3-7.
20. Tsushima H (1993) Clinical study on the cell kinetics of gastric cancer using bromodeoxyuridine labeling index its relations with DNA ploidy pattern and epidermal growth factor Nippon Geka Gakkai Zasshi 94: 41-49.
21. Wato M, Nishikawa T, Fujita A, Nagao Y, Tsujimoto K, Matsuoka K, Horii K, Okano H, Tanaka A (1993) Application of in vitro bromodeoxyuridine labeling of oral cancers. J Osaka Dent Univ 27: 113-120.
22. Weissman IL (2000) Stem cells: units of development, units of regeneration and units in evolution. Cell 100: 157-168.
23. Yanai T, Masegi T, Tomita A, Kudo T, Yamazoe K, Iwasaki T, Kimura N, Katou A, Kotera S, Ueda K (1995) Odontoameloblastoma in a Japanese monkey (Macaca fuscata). Vet Pathol 32: 57-59.
24. Yanai T, Matsumoto C, Takashima H, Yoshida K, Sakai H, Isowa K, Iwasaki T, Sato Y, Masegi T (1996) Immunohistochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in cattle tissues. J Comp Pathol 114: 265-272.
25. Yonemura Y, Miyazaki I (1990) Quantitative estimation of malignancy of gastric cancer by DNA ploidy and proliferative activities. Rinsho Byori 38: 1053-1058.
26. Yoshida K, Yanai T, Iwasaki T, Sakai H, Ohta J, Kati S, Ishikawa K, Lackner AA, Masegi T (1999) Proliferative potential of canine oral epulides and malignant neoplasms assessed by bromodeoxyuridine labeling. Vet Path 36: 35-41.